Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
SXI Quote, Financials, Valuation and Earnings
Last price:
$156.91
Seasonality move
:
3.54%
Day range:
$153.45 - $157.73
52-week range:
$128.85 - $212.66
Dividend yield:
0.81%
P/E ratio:
30.88x
P/S ratio:
2.50x
P/B ratio:
2.75x
Volume:
127.8K
Avg. volume:
134.1K
1-year change:
-15.38%
Market cap:
$1.9B
Revenue:
$720.6M
EPS (TTM):
$5.06
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $604.5M | $656.2M | $735.3M | $741M | $720.6M | |
| Revenue Growth (YoY) | -5.53% | 8.55% | 12.06% | 0.78% | -2.76% | |
| Cost of Revenues | $389.1M | $415M | $465.4M | $456M | $438.6M | |
| Gross Profit | $215.5M | $241.3M | $269.9M | $285.1M | $282M | |
| Gross Profit Margin | 35.64% | 36.77% | 36.71% | 38.47% | 39.13% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $148.5M | $163.1M | $169.9M | $172.3M | $169.6M | |
| Other Inc / (Exp) | -$5.4M | -$19.5M | -$7.1M | $56M | -$12.6M | |
| Operating Expenses | $148.5M | $163.1M | $175.6M | $171.7M | $169.7M | |
| Operating Income | $67M | $78.2M | $94.3M | $113.4M | $112.3M | |
| Net Interest Expenses | $7.5M | $6M | $5.9M | $5.4M | $4.5M | |
| EBT. Incl. Unusual Items | $54.1M | $52.7M | $81.3M | $163.9M | $95.1M | |
| Earnings of Discontinued Ops. | -$20.8M | -$2.1M | -$89K | -$161K | -$517K | |
| Income Tax Expense | $13.1M | $14.2M | $19.8M | $24.8M | $21.5M | |
| Net Income to Company | $41M | $38.5M | $61.5M | $139.2M | $73.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $20.2M | $36.5M | $61.4M | $139M | $73.1M | |
| Basic EPS (Cont. Ops) | $1.64 | $3.00 | $5.13 | $11.77 | $6.22 | |
| Diluted EPS (Cont. Ops) | $1.63 | $2.97 | $5.06 | $11.58 | $6.14 | |
| Weighted Average Basic Share | $12.3M | $12.2M | $12M | $11.8M | $11.8M | |
| Weighted Average Diluted Share | $12.4M | $12.3M | $12.1M | $12M | $11.9M | |
| EBITDA | $93.8M | $91.9M | $116.9M | $197.8M | $127.8M | |
| EBIT | $61.5M | $58.7M | $87.2M | $169.4M | $99.7M | |
| Revenue (Reported) | $604.5M | $656.2M | $735.3M | $741M | $720.6M | |
| Operating Income (Reported) | $67M | $78.2M | $94.3M | $113.4M | $112.3M | |
| Operating Income (Adjusted) | $61.5M | $58.7M | $87.2M | $169.4M | $99.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $172.2M | $189.3M | $184.3M | $177.3M | $207.8M | |
| Revenue Growth (YoY) | 10.77% | 9.91% | -2.62% | -3.83% | 17.21% | |
| Cost of Revenues | $109.5M | $120.9M | $113.4M | $109M | $125.4M | |
| Gross Profit | $62.7M | $68.4M | $70.9M | $68.3M | $82.4M | |
| Gross Profit Margin | 36.41% | 36.13% | 38.46% | 38.52% | 39.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $41.7M | $42.3M | $43M | $41.8M | $52M | |
| Other Inc / (Exp) | -$15.7M | -$1.9M | $59.1M | -$5.2M | -$4.4M | |
| Operating Expenses | $41.7M | $42.3M | $42.2M | $41.9M | $52M | |
| Operating Income | $21M | $26.1M | $28.7M | $26.4M | $30.4M | |
| Net Interest Expenses | $1.3M | $1.2M | $1.4M | $949K | $8.4M | |
| EBT. Incl. Unusual Items | $4M | $22.9M | $86.4M | $20.3M | $17.6M | |
| Earnings of Discontinued Ops. | -$331K | -$86K | -$57K | -$141K | -$52K | |
| Income Tax Expense | $2.3M | $5.5M | $5.8M | $4.3M | -$5.2M | |
| Net Income to Company | $1.8M | $17.4M | $80.6M | $15.9M | $22.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$846K | |
| Net Income to Common Excl Extra Items | $1.4M | $17.3M | $80.5M | $15.8M | $21.9M | |
| Basic EPS (Cont. Ops) | $0.11 | $1.44 | $6.82 | $1.34 | $1.83 | |
| Diluted EPS (Cont. Ops) | $0.11 | $1.34 | $6.77 | $1.33 | $1.81 | |
| Weighted Average Basic Share | $12.1M | $12M | $11.8M | $11.8M | $12M | |
| Weighted Average Diluted Share | $12.3M | $12.1M | $11.9M | $11.8M | $12.1M | |
| EBITDA | $13.7M | $31.3M | $95.1M | $28.4M | $35.7M | |
| EBIT | $5.3M | $24.1M | $87.8M | $21.2M | $25.9M | |
| Revenue (Reported) | $172.2M | $189.3M | $184.3M | $177.3M | $207.8M | |
| Operating Income (Reported) | $21M | $26.1M | $28.7M | $26.4M | $30.4M | |
| Operating Income (Adjusted) | $5.3M | $24.1M | $87.8M | $21.2M | $25.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $619.2M | $727M | $737.5M | $728.8M | $748.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $396.8M | $457.8M | $459.4M | $442.6M | $454.9M | |
| Gross Profit | $222.4M | $269.2M | $278M | $286.2M | $293.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $155.6M | $170.9M | $169.1M | $173.2M | $181.7M | |
| Other Inc / (Exp) | -$19.6M | -$6.2M | $54.1M | -$11.7M | -$27.1M | |
| Operating Expenses | $155.6M | $172.6M | $172.5M | $173.3M | $181.7M | |
| Operating Income | $66.8M | $96.6M | $105.5M | $112.9M | $111.6M | |
| Net Interest Expenses | $6.1M | $6.1M | $5.6M | $4.5M | $16.2M | |
| EBT. Incl. Unusual Items | $41.2M | $84.4M | $154.1M | $96.7M | $68.3M | |
| Earnings of Discontinued Ops. | -$5.9M | -$617K | -$98K | -$437K | -$153K | |
| Income Tax Expense | $11M | $21.7M | $21.9M | $22.7M | $6.4M | |
| Net Income to Company | $30.2M | $62.7M | $132.2M | $74.1M | $61.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$1.3M | |
| Net Income to Common Excl Extra Items | $24.4M | $62.1M | $132.1M | $73.7M | $60.5M | |
| Basic EPS (Cont. Ops) | $1.99 | $5.17 | $11.18 | $6.25 | $5.11 | |
| Diluted EPS (Cont. Ops) | $1.98 | $5.02 | $11.09 | $6.18 | $5.06 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $80.1M | $121.3M | $188.2M | $129.6M | $116.8M | |
| EBIT | $47.3M | $90.4M | $159.7M | $101.2M | $84.5M | |
| Revenue (Reported) | $619.2M | $727M | $737.5M | $728.8M | $748.3M | |
| Operating Income (Reported) | $66.8M | $96.6M | $105.5M | $112.9M | $111.6M | |
| Operating Income (Adjusted) | $47.3M | $90.4M | $159.7M | $101.2M | $84.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $479.8M | $550.6M | $552.7M | $540.4M | $568.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $304.3M | $347.2M | $341.3M | $327.9M | $344.1M | |
| Gross Profit | $175.5M | $203.4M | $211.5M | $212.6M | $224M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $120.8M | $128.6M | $127.8M | $128.6M | $140.8M | |
| Other Inc / (Exp) | -$18M | -$4.7M | $56.6M | -$11.1M | -$25.5M | |
| Operating Expenses | $120.8M | $130.3M | $127.1M | $128.7M | $140.8M | |
| Operating Income | $54.7M | $73.1M | $84.3M | $83.9M | $83.2M | |
| Net Interest Expenses | $4.4M | $4.5M | $4.2M | $3.2M | $14.9M | |
| EBT. Incl. Unusual Items | $32.3M | $63.9M | $136.8M | $69.5M | $42.7M | |
| Earnings of Discontinued Ops. | -$1.6M | -$135K | -$144K | -$420K | -$56K | |
| Income Tax Expense | $8.2M | $15.7M | $17.8M | $15.6M | $475K | |
| Net Income to Company | $24.1M | $48.3M | $119M | $53.9M | $42.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$1.3M | |
| Net Income to Common Excl Extra Items | $22.5M | $48.1M | $118.8M | $53.5M | $40.9M | |
| Basic EPS (Cont. Ops) | $1.84 | $4.01 | $10.06 | $4.54 | $3.44 | |
| Diluted EPS (Cont. Ops) | $1.83 | $3.88 | $9.99 | $4.50 | $3.41 | |
| Weighted Average Basic Share | $36.6M | $36M | $35.5M | $35.3M | $35.7M | |
| Weighted Average Diluted Share | $36.8M | $36.4M | $35.8M | $35.6M | $36M | |
| EBITDA | $61.5M | $90.8M | $162.2M | $93.9M | $83M | |
| EBIT | $36.7M | $68.4M | $140.9M | $72.8M | $57.6M | |
| Revenue (Reported) | $479.8M | $550.6M | $552.7M | $540.4M | $568.1M | |
| Operating Income (Reported) | $54.7M | $73.1M | $84.3M | $83.9M | $83.2M | |
| Operating Income (Adjusted) | $36.7M | $68.4M | $140.9M | $72.8M | $57.6M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $118.8M | $136.4M | $104.8M | $195.7M | $154.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $98.2M | $109.9M | $117.1M | $123.4M | $121.4M | |
| Inventory | $85M | $91.9M | $105.3M | $98.5M | $87.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $18.9M | $23.5M | $45.2M | $34.4M | $22M | |
| Total Current Assets | $332M | $374.4M | $379M | $483.3M | $430.1M | |
| Property Plant And Equipment | $177.3M | $170.6M | $167.7M | $164.2M | $172M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $271.2M | $278.1M | $267.9M | $264.8M | $281.3M | |
| Other Intangibles | $106.4M | $98.9M | $85.8M | $75.7M | $78.7M | |
| Other Long-Term Assets | $26.6M | $30.7M | $25.9M | $22.4M | $25.5M | |
| Total Assets | $930.9M | $962.2M | $934.4M | $1B | $1B | |
| Accounts Payable | $54.9M | $74.8M | $74.5M | $68.6M | $63.4M | |
| Accrued Expenses | $38.2M | $45.3M | $56.3M | $48.7M | $45.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8M | $7.9M | $7.9M | $8M | $8.3M | |
| Other Current Liabilities | $9.8M | $4.3M | -- | $1.7M | -- | |
| Total Current Liabilities | $122.9M | $143.7M | $150.8M | $141M | $127.6M | |
| Long-Term Debt | $199.2M | $199.5M | $174.8M | $173.4M | $148.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $469.2M | $455.8M | $435.1M | $417.5M | $383.6M | |
| Common Stock | $42M | $42M | $42M | $42M | $42M | |
| Other Common Equity Adj | -$147.7M | -$116.1M | -$153.3M | -$158.5M | -$183M | |
| Common Equity | $461.6M | $506.4M | $499.3M | $607.4M | $621.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $461.6M | $506.4M | $499.3M | $607.4M | $621.5M | |
| Total Liabilities and Equity | $930.9M | $962.2M | $934.4M | $1B | $1B | |
| Cash and Short Terms | $118.8M | $136.4M | $104.8M | $195.7M | $154.2M | |
| Total Debt | $199.2M | $199.5M | $174.8M | $173.4M | $148.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $118M | $133.9M | $175.3M | $138.8M | $109.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $108M | $115.4M | $121.2M | $120.5M | $169.9M | |
| Inventory | $90.9M | $103.9M | $104.5M | $95.2M | $120M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $22.6M | $41.8M | $56.6M | $62.1M | $28.8M | |
| Total Current Assets | $350.8M | $410.6M | $460.8M | $419.2M | $486.9M | |
| Property Plant And Equipment | $169M | $163.7M | $166.7M | $169.4M | $190M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $277.9M | $275.1M | $269.5M | $282M | $610.7M | |
| Other Intangibles | $102.1M | $91.5M | $79.6M | $81.9M | $226.8M | |
| Other Long-Term Assets | $29.6M | $27.1M | $29.4M | $26M | $23.5M | |
| Total Assets | $946.3M | $973.6M | $1B | $993.5M | $1.6B | |
| Accounts Payable | $66.6M | $75.3M | $67.5M | $58.4M | $76.5M | |
| Accrued Expenses | $41.5M | $46M | $43.5M | $44M | $40.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8.4M | $6.8M | $8.1M | $7.9M | $10M | |
| Other Current Liabilities | $4.5M | $331K | $1.1M | -- | -- | |
| Total Current Liabilities | $131.9M | $141.7M | $130.6M | $122.3M | $143.1M | |
| Long-Term Debt | $200.1M | $199.7M | $173.3M | $148.8M | $579.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $463.7M | $445.9M | $409.5M | $374.5M | $840.1M | |
| Common Stock | $42M | $42M | $42M | $42M | $42M | |
| Other Common Equity Adj | -$131M | -$121.9M | -$147.2M | -$168M | -$177.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $27.6M | |
| Total Equity | $482.7M | $527.6M | $605.6M | $619M | $714.5M | |
| Total Liabilities and Equity | $946.3M | $973.6M | $1B | $993.5M | $1.6B | |
| Cash and Short Terms | $118M | $133.9M | $175.3M | $138.8M | $109.8M | |
| Total Debt | $200.1M | $199.7M | $173.3M | $148.8M | $579.4M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41M | $38.5M | $61.5M | $139.2M | $73.6M | |
| Depreciation & Amoritzation | $32.3M | $33.2M | $29.7M | $28.5M | $28.1M | |
| Stock-Based Compensation | $7M | $8.4M | $11.2M | $11.7M | $9.8M | |
| Change in Accounts Receivable | $2.3M | -$5.5M | -$11.6M | -$9.6M | $16.2M | |
| Change in Inventories | -$9.1M | -$7.7M | -$18.2M | -$912K | $17.1M | |
| Cash From Operations | $47.2M | $83.6M | $77.7M | $90.8M | $92.7M | |
| Capital Expenditures | $21.5M | $21.8M | $23.9M | $24.3M | $20.3M | |
| Cash Acquisitions | -$622K | -$15.7M | -$13M | $67M | -$41.1M | |
| Cash From Investing | -$617K | -$39.1M | -$31M | $41.6M | -$61.6M | |
| Dividends Paid (Ex Special Dividend) | -$10.6M | -$11.4M | -$12.2M | -$13M | -$13.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $106.5M | $17M | -- | $224.5M | -- | |
| Long-Term Debt Repaid | -$105.3M | -$17M | -$25M | -$226.2M | -$25M | |
| Repurchase of Common Stock | -$10.4M | -$21.2M | -$31.4M | -$25.5M | -$31.8M | |
| Other Financing Activities | -$872K | -$356K | -$2.2M | -$1.2M | -- | |
| Cash From Financing | -$19M | -$31.7M | -$69.4M | -$40M | -$69.2M | |
| Beginning Cash (CF) | $93.1M | $118.8M | $136.4M | $104.8M | $195.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $27.6M | $12.8M | -$22.8M | $92.3M | -$38.2M | |
| Ending Cash (CF) | $118.8M | $136.4M | $104.8M | $195.7M | $154.2M | |
| Levered Free Cash Flow | $25.7M | $61.8M | $53.8M | $66.5M | $72.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8M | $17.4M | $80.6M | $15.9M | $22.8M | |
| Depreciation & Amoritzation | $8.3M | $7.2M | $7.3M | $7.2M | $9.7M | |
| Stock-Based Compensation | $1.4M | $3.6M | $3.8M | $3.7M | $2.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.8M | $11.9M | $23.3M | $24.4M | $9.5M | |
| Capital Expenditures | $5.5M | $3.4M | $5.6M | $5.2M | $6.1M | |
| Cash Acquisitions | $11.7M | -$9.9M | $67M | -$11M | -$57.7M | |
| Cash From Investing | $4.5M | -$9.2M | $60M | -$16.4M | -$63.9M | |
| Dividends Paid (Ex Special Dividend) | -$2.9M | -$3.1M | -$3.3M | -$3.5M | -$3.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $196M | -- | $68M | |
| Long-Term Debt Repaid | -- | -- | -$210.2M | -- | -$23M | |
| Repurchase of Common Stock | -$8.6M | -$11.9M | -$5.1M | -$5.1M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$1K | |
| Cash From Financing | -$11.4M | -$14.8M | -$22.4M | -$8.5M | $41.4M | |
| Beginning Cash (CF) | $109.1M | $147.2M | $113.5M | $142.4M | $121.1M | |
| Foreign Exchange Rate Adjustment | -$2M | -$1.1M | $917K | -$3M | $1.6M | |
| Additions / Reductions | $10.9M | -$12.2M | $60.9M | -$578K | -$13M | |
| Ending Cash (CF) | $118M | $133.9M | $175.3M | $138.8M | $109.8M | |
| Levered Free Cash Flow | $12.3M | $8.5M | $17.7M | $19.2M | $3.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $30.2M | $62.7M | $132.2M | $74.1M | $61.9M | |
| Depreciation & Amoritzation | $32.8M | $30.8M | $28.6M | $28.3M | $32.3M | |
| Stock-Based Compensation | $7.4M | $10.9M | $11.5M | $11.7M | $9.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $72.9M | $80.3M | $79.8M | $104.6M | $64.7M | |
| Capital Expenditures | $21.3M | $19.3M | $27.4M | $21.4M | $26.3M | |
| Cash Acquisitions | -$16.4M | -$9.9M | $63.9M | -$39.9M | -$478.5M | |
| Cash From Investing | -$28.5M | -$23.6M | $35.3M | -$61.4M | -$501M | |
| Dividends Paid (Ex Special Dividend) | -$11.2M | -$12.1M | -$12.8M | -$13.7M | -$14.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $17M | -- | $224.5M | -- | -- | |
| Long-Term Debt Repaid | -$30M | -- | -$251.2M | -$25M | -$362.1M | |
| Repurchase of Common Stock | -$17.6M | -$26.4M | -$28.6M | -$38.7M | -$9.6M | |
| Other Financing Activities | -- | -- | -$2.2M | -- | -- | |
| Cash From Financing | -$40.6M | -$38.5M | -$69M | -$75.9M | $408.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.7M | $18.1M | $46.1M | -$32.7M | -$28.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $51.5M | $61M | $52.4M | $83.2M | $38.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $24.1M | $48.3M | $119M | $53.9M | $42.3M | |
| Depreciation & Amoritzation | $24.8M | $22.4M | $21.3M | $21.1M | $25.3M | |
| Stock-Based Compensation | $5.7M | $8.2M | $8.5M | $8.5M | $7.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $51.6M | $48.3M | $50.3M | $64.1M | $36.2M | |
| Capital Expenditures | $15.6M | $13.1M | $16.6M | $13.8M | $19.8M | |
| Cash Acquisitions | -$15.7M | -$9.9M | $67M | -$39.9M | -$477.4M | |
| Cash From Investing | -$32.8M | -$17.3M | $49.1M | -$54M | -$493.3M | |
| Dividends Paid (Ex Special Dividend) | -$8.5M | -$9.1M | -$9.7M | -$10.4M | -$11.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $17M | -- | $224.5M | -- | $792.3M | |
| Long-Term Debt Repaid | -$17M | -- | -$226.2M | -$25M | -$362.1M | |
| Repurchase of Common Stock | -$16.2M | -$21.4M | -$18.6M | -$31.8M | -$9.6M | |
| Other Financing Activities | -- | -$1.2M | -$1.2M | -- | -$1K | |
| Cash From Financing | -$23.6M | -$30.4M | -$30M | -$65.8M | $411.4M | |
| Beginning Cash (CF) | $321.6M | $414.2M | $321.8M | $465M | $439.9M | |
| Foreign Exchange Rate Adjustment | $4.1M | -$3M | $1M | -$1.2M | $1.3M | |
| Additions / Reductions | -$4.9M | $514K | $69.4M | -$55.7M | -$45.7M | |
| Ending Cash (CF) | $320.8M | $411.7M | $392.2M | $408.1M | $395.5M | |
| Levered Free Cash Flow | $36M | $35.1M | $33.7M | $50.3M | $16.4M | |
Get SXI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SXI
Sector
P/E ratio
30.88x
18.58x
PEG ratio
--
0.25x
P/B ratio
2.75x
1.75x
Price / LTM sales
2.50x
0.94x
Growth Metrics
SXI
Sector
Revenue growth
17.21%
1.98%
Earnings growth
36.09%
2.46%
Revenue (5-year growth)
2.4%
4.35%
Earnings forecast
$2.10
$0.40
Profitability
SXI
Sector
Profitability FY 2024
$282M
$393.9M
Return on invested capital
6.23%
5.32%
Return on assets
4.98%
3.49%
Return on equity
9.18%
8.55%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31
Balance Sheet
SXI
Sector
Total cash
$109.8M
$154.3M
Short term investments
--
$35.5M
Total assets
$1B
$1.7B
Long term debt
$579.4M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
